Value of measuring diurnal peak flow variability in the recognition of asthma: A study in general practice

European Respiratory Journal

Volumn 12, Issue 4, 1998, Pages 842-847

  Thiadens, H A ^a,d   De Bock, G H ^a   Dekker, F W ^b   Huysman, J A N ^a   Van Houwelingen, J C ^a   Springer, M P ^a   Postma, D S ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Diagnosis; Diurnal peak flow variability; Female sex

Indexed keywords

METHACHOLINE;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; DIAGNOSTIC VALUE; FEMALE; GENDER; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; ADULT; AGED; ASTHMA; BRONCHIAL PROVOCATION TESTS; CIRCADIAN RHYTHM; COUGH; DIAGNOSIS, DIFFERENTIAL; FAMILY PRACTICE; FEMALE; HUMANS; LOGISTIC MODELS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PROBABILITY; SENSITIVITY AND SPECIFICITY;

EID: 0031754119     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12040842     Document Type: Article

References (24)

1. Dutch Guidelines on diagnosing asthma or COPD. Huisarts Wet 1992; 35: 430-436.
2. National Heart, Lung and Blood Institute. International Consensus Report on Diagnosis and Management of Asthma. Eur Respir J 1992; 5: 601-641.
3. National Institutes of Health, National Heart, Lung and Blood Institute. Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/ WHO Workshop Report. Publication number 95-3695, 1995.
4. Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 1990; 85: 1098-1110.
5. Higgins BG, Britton JR, Chinn S, Cooper S, Burney PGJ, Tattersfield AE. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiological studies. Am Rev Respir Dis 1992; 145: 588-593.
6. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982; 37: 423-429.
7. Partridge MR. Patients self-assessment and treatment strategies for acute asthma. Res Clin Forums 1993; 15: 65-75.
8. Higgins BG, Britton JR, Chinn S, et al. The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis 1989; 140: 1368-1372.
9. Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates: relationship to symptoms and respiratory disease. Am Rev Respir Dis 1991; 143: 323-330.
10. Boezen HM, Scheuten JP, Postma DS, Rijcken B. Distribution of peak expiratory flow variability by age, gender and smoking habits in a random population sample aged 20-70. Eur Respir J 1994; 7: 1814-1820.
11. Thiadens HA, De Bock GH, Dekker FW, et al. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study. BMJ 1998; 316: 1286-1290.
12. Lende R van de, Orie NGM. The MRC-ECCS questionnaire on respiratory symptoms (use in epidemiology). Scand J Respir Dis 1972; 53: 218-226.
13. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6: Suppl. 16, 5-40.
14. Dales RE, Spitzer WO, Toussignant P, Schlechter M, Uissa S. Clinical interpretation of airway response to a bronchodilator. Am Rev Respir Dis 1988; 138: 317-320.
15. Brand PLP, Quanjer PH, Postma DS, Kerstjens HAM, Koeter GH, Dekhuijzen RPN and the Dutch CNSLD study group. Interpretation of bronchodilator response to bronchodilators in patients with obstructive airways disease. Thorax 1992; 47: 429-436.
16. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38: 760-765.
17. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). ERS-Consensus statement. Ear Respir J 1995; 8: 1398-1420.
18. Brand PLP, Postma DS, Kerstjens HAM, Koëter GH and the Dutch CNSLD Study Group. Relationship of airways hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143: 323-330.
19. Hetzel MR, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35: 732-738.
20. Boezen HM, Schouten JP, Postma DS, Rijcken B. Relation between respiratory symptoms, pulmonary function and peak flow variability in adults. Thorax 1995; 50: 121-126.
21. Jamison JP, McKinley RK. Validity of peak expiratory flow rate variability for the diagnosis of asthma. Clin Sci 1993; 85: 367-371.
22. Trigg CJ, Bennet JB, Sibbald B, Souza MF, Davies RJ. A general practice based survey of bronchial hyperresponsiveness and its relation to symptoms, sex, age, atopy, and smoking. Thorax 1990; 45: 866-872.
23. Woolcock AJ, Peat JK, Salome CM, et al. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax 1987; 42: 361-368.
24. Burney PGJ, Britton JR, Chinn S, et al. Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax 1987; 42: 38-44.